9,230
Total Claims
$811K
Drug Cost
531
Beneficiaries
$1,528
Cost/Patient
Peer Comparison vs. 106,889 Family Practice providers
+43%
Cost per patient vs peers
$1,528 vs $1,068 avg
+22%
Brand preference vs peers
11.0% vs 9.0% avg
Brand vs Generic
89% generic
Brand: 1,008 claims · $630K
Generic: 8,185 claims · $179K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 107 | $109K |
| Empagliflozin | 55 | $61K |
| Semaglutide | 51 | $57K |
| Rivaroxaban | 31 | $39K |
| Dapagliflozin Propanediol | 31 | $30K |
| Budesonide/Formoterol Fumarate | 48 | $28K |
| Dulaglutide | 17 | $25K |
| Sacubitril/Valsartan | 15 | $21K |
| Tiotropium Bromide | 23 | $15K |
| Insulin Glargine,hum.Rec.Anlog | 23 | $12K |
| Fluticasone/Vilanterol | 19 | $11K |
| Budesonide/Glycopyr/Formoterol | 11 | $8,729 |
| Atorvastatin Calcium | 610 | $8,684 |
| Fluticasone Propion/Salmeterol | 14 | $7,763 |
| Evolocumab | 12 | $7,110 |
Prescribing Profile
Patient Profile
73
Avg Age
56%
Female
1.36
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data